Xeris Biopharma President and COO Kevin McCulloch Reports Sale of Common Shares Worth $312,215

PUBT · 3d ago
Xeris Biopharma President and COO Kevin McCulloch Reports Sale of Common Shares Worth $312,215
  • Xeris Biopharma President and Chief Operating Officer Kevin McCulloch sold 25,000 common shares on November 5, 2026.
  • The sale price was $12.4886 per share, leaving direct holdings of 1,559,208 shares.
  • The November 6, 2026, filing also reported 25,000 common shares held indirectly through his spouse.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001867096-26-000119), on November 06, 2026, and is solely responsible for the information contained therein.